Trends in incidence and mortality of Alzheimer's disease in Zhejiang Province from 2003 to 2017
WANG Hao1, LI Na1, YU Jianan2, PAN Jin1, GONG Weiwei1, ZHOU Xiaoyan1, GUAN Yunqi1, DAI Pinyuan1, YU Min3
1. Department of Non-communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China; 2. Dinghai Center for Disease Control and Prevention, Zhoushan, Zhejiang 316000, China; 3. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
Abstract：Objective To analyze the trends in incidence and mortality of Alzheimer's disease (AD) in Zhejiang Province from 2003 to 2017, so as to provide the evidence for the development of AD prevention and control strategies. Methods The data pertaining to the incidence and mortality of AD in China from 2003 to 2017 were collected from the Global Burden Disease Study, and standardized to the data of the Sixth National Population Census in China in 2010. The trends in incidence and mortality of AD were analyzed using annual percent change (APC) and average annual percent change ( AAPC ) in Zhejiang Province from 2003 to 2017. Results The incidence of AD increased from 96.05/105 in 2003 to 140.96/105 in 2017 in Zhejiang Province, with AAPC of 2.776% ( P<0.05 ), and the greatest APC ( 3.419% ) was found during the period between 2003 and 2005 ( P<0.05 ). The standardized incidence of AD increased 102.06/105 in 2003 to 106.09/105 in 2017 in Zhejiang Province, with AAPC of 0.274% ( P<0.05 ), and the greatest APC ( 1.177% ) was measured during the period between 2003 and 2005 ( P<0.05). The mortality of AD increased from 24.60/105 in 2003 to 41.44/105 in 2017 in Zhejiang Province, with AAPC of 3.862% ( P<0.05 ), and the greatest APC (4.667%) was found during the period between 2005 and 2011 ( P<0.05 ). The standardized mortality of AD increased 26.83/105 in 2003 to 27.16/105 in 2017 in Zhejiang Province, with AAPC of 0.142% ( P>0.05 ), and the greatest APC ( 1.048% ) was measured during the period between 2005 and 2012 ( P<0.05 ). Conclusion Both the incidence and mortality of AD appeared a tendency towards a rise in Zhejiang Province from 2003 to 2017.
王浩, 李娜, 俞佳男, 潘劲, 龚巍巍, 周晓燕, 关云琦, 戴品远, 俞敏. 2003—2017年浙江省阿尔茨海默病发病和死亡趋势分析[J]. 预防医学, 2022, 34(3): 227-231,239.
WANG Hao, LI Na, YU Jianan, PAN Jin, GONG Weiwei, ZHOU Xiaoyan, GUAN Yunqi, DAI Pinyuan, YU Min. Trends in incidence and mortality of Alzheimer's disease in Zhejiang Province from 2003 to 2017. Preventive Medicine, 2022, 34(3): 227-231,239.
[1] GBD 2016 Dementia Collaborators.Global,regional,and national burden of Alzheimer's disease and other dementias,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016BD 2016 Dementia Collaborators.Global,regional,and national burden of Alzheimer's disease and other dementias,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet Neurol,2019,18(1):88-106. [2] 陈庆华,张凤强,李立新,等.阿尔茨海默病发病机制和诊断技术研究进展[J].中华老年心脑血管病杂志,2018,20(1):108-110. CHEN Q H,ZHANG F Q,LI L X,et al.Research progress in the pathogenesis and diagnosis technology of Alzheimer's disease[J].Chin J Geriatr Heart Brain Ves Dis,2018,20(1):108-110. [3] 章瑜,谢健,朱大荣.阿尔茨海默病伴精神行为症状患者低频振幅功能磁共振研究[J].预防医学,2018,30(11):1106-1111. ZHANG Y,XIE J,ZHU D R.Application of fMRI with amplitude of low-frequency fluctuation to behavioral and psychological symptoms in patients with Alzheimer's disease[J].Prev Med,2018,30(11):1106-1111. [4] MURRAY C J,VOS T,LOZANO R,et al.Disability-adjusted life years(DALYs)for 291 diseases and injuries in 21 regions,1990-2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet,2012,380(9859):2197-2223. [5] 周薇,张志将,毕勇毅,等.中国女性1987—2014年乳腺癌死亡趋势的Joinpoint回归分析[J].中南大学学报(医学版),2018,43(2):210-215. ZHOU W, ZHANG Z J,BI Y Y,et al.Joinpoint regression analysis for the mortality trend of breast cancer in Chinese female from 1987 to 2014[J]. J Cent South Univ(Med Sci),2018,43(2):210-215. [6] ZHOU M,WANG H,ZENG X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158. [7] GRODD W,BECKMANN C F.Resting state functional MRI of the brain[J].Nervenarzt,2014,85(6):690-700. [8] HEBERT L E,SCHERR P A,MCCANN J J,et al.Is the risk of developing Alzheimer's disease greater for women than for men?[J].Am J Epidemiol,2001,153(2):132-136. [9] CHENE G,BEISER A,AU R,et al.Gender and incidence of dementia in the Framingham Heart Study from mid-adult life[J].Alzheimers Dement,2015,11(3):310-320. [10] LIVINGSTON G,SOMMERLAD A,ORGETA V,et al.Dementia prevention,intervention,and care[J].Lancet,2017,390(10113):2673-2734. [11] UNGAR L,ALTMANN A,GREICIUS M D.Apolipoprotein E,gender,and Alzheimer's disease:an overlooked,but potent and promising interaction[J].Brain Imaging Behav,2014,8(2):262-273. [12] GAUTHIER S,ALBERTT M,FOX N,et al.Why has therapy development for dementia failed in the last two decades?[J].Alzheimers Dement,2016,12(1):60-64. [13] BAUMGART M,NYDER H M,CARRILLO M C,et al.Summary of the evidence on modifiable risk factors for cognitive decline and dementia:a population-based perspective[J].Alzheimers Dement,2015,11(6):718-726. [14] JIANG Y F,MAN Q H,LIU Z Q,et al.Temporal trends in the mortality rate of Alzheimer's disease and other dementias attributable to smoking,1990-2017[J/OL].Environ Res,2020,184[2021-12-31].https://doi.org/10.1016/j.envres.2020.109183. [15] 胡如英,展元元,王蒙,等.浙江省成人吸烟行为趋势研究[J].预防医学,2018,30(12):1189-1194. HU R Y,ZHAN Y Y,WANG M,et al.Prevalence and trend of adult smoking in Zhejiang Province[J].Prev Med,2018,30(12):1189-1194. [16] KIVIPELTO M,MANGIALASCHE F,NGANDU T.Lifestyle interventions to prevent cognitive impairment,dementia and Alzheimer's disease[J].Nat Rev Neurol,2018,14(11):653-666. [17] CROUS-BOU M,MINGUILLON C,GRAMUNT N,et al.Alzheimer's disease prevention:from risk factors to early intervention[J].Alzheimers Res Ther,2017,9(1):1-9.
